Gilead Sciences reported $2.25B in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4441M 338M
Acorda Therapeutics ACOR:US $ -15.69M 13.09M
Agios Pharmaceuticals AGIO:US $ -89.22M 2M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
ALKERMES ALKS:US 4.42M 22.95M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Amgen AMGN:US $ 828M 1301M
Arena Pharmaceuticals ARNA:US $ -144.39M 12.4M
Biogen BIIB:US $ 485.7M 488.2M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Bluebird Bio BLUE:US $ -240.84M 9.63M
Bristol Myers Squibb BMY:US $ 1715M 36M
Coherus Biosciences CHRS:US $ -24.16M 143.2M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Gilead Sciences GILD:US $ 2246M 644M
GlaxoSmithKline GSK:LN 1.68B 18M
Glaxosmithkline GSK:US $ 1675M 18M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
Johnson & Johnson JNJ:US $ 6662M 767M
Merk MRK:US $ 1497M 1517M
Moderna Inc MRNA:US 3.06B 1.8B
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Novartis NOVN:VX 3.48B 1.06B
Pfizer PFE:US $ 5914M 397M
Ptc Therapeutics PTCT:US $ -98.49M 0.34M
Puma Biotechnology PBYI:US $ -1.73M 21.69M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
Teva Pharmaceutical Industries TEVA:US $ 582M 148M
United Therapeutics UTHR:US $ 219.9M 284.7M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
YTE INCY:US $ 140.84M 42.04M